Aethlon Medical Inc (NAS:AEMD)
$ 0.4 -0.4501 (-52.95%) Market Cap: 1.05 Mil Enterprise Value: -4.73 Mil PE Ratio: 0 PB Ratio: 0.14 GF Score: 51/100

Q2 2024 Aethlon Medical Inc Earnings Call Transcript

Nov 14, 2023 / 09:30PM GMT
Release Date Price: $1.66 (+0.30%)
Operator

Good day and welcome to the Aethlon Medical second-quarter fiscal 2024 earnings and corporate update call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Mr. Michael Miller with Rx Communications. Please go ahead, sir.

Michael Miller Rx Communications Group
LLC - IR

Thank you, operator, and good afternoon, everyone. Welcome to Aethlon Medical's second-quarter fiscal 2024 earnings conference call. My name is Michael Miller with Rx Communications. At 4:15 PM Eastern Time today, Aethlon Medical released financial results for its second fiscal quarter ended September 30, 2023. If you have not seen or received Aethlon Medical's earnings release, please visit the Investor page at www.aethlonmedical.com.

Following this introduction and the reading of the company's forward-looking statement, Aethlon's Interim Chief Executive Officer and Chief Financial Officer, James Frakes; and Aethlon's Chief Medical Officer, Dr. Steven

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot